Related MeSH Hierarchy (5)
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Genital Diseases, Male » Genital Neoplasms, Male
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Genital Neoplasms, Male
Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Male » Genital Neoplasms, Male
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Genital Neoplasms, Male
Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Genital Neoplasms, Male
Description
Tumor or cancer of the MALE GENITALIA. MeSH
Hierarchy View
Subtype Terms (3)
Penile Neoplasms
59 drugs (35 approved, 24 experimental)
Prostatic Neoplasms
1055 drugs (397 approved, 658 experimental)
Testicular Neoplasms
142 drugs (92 approved, 50 experimental)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 2 Indications (13)
Organization Involved with Phase 1 Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
